Published on July 15th, 2008 | by Kristin Dispenza


Shaver Green Building to Offer Sustainable Workforce Housing

Rendering of the Shaver Green Apartment Building in Portland, Oregon“Workforce housing” is a term being heard more and more, used place of the more familiar “affordable housing”. It differentiates between housing that is intended to accommodate people from the lowest income brackets, and housing for the lower middle class, people who have steady employment but have been priced out of the housing market in many areas.

According to Wikipedia, workforce housing has four defining elements:

  • Affordability
  • Home Ownership
  • Key Workforce (in other words, composed of critical members of a community’s workforce such as police officers and teachers), and
  • Proximity (to employment centers)

In May, groundbreaking was held for the Shaver Green Building in Portland, Oregon, on a site previously considered blighted. Shaver Green, a six-story, 89,000 sq. ft. apartment building designed by DECA Architecture, will offer 85 housing units. Seventy-five of these units will be workforce housing, intended for persons earning 60% or less than the county’s median income. Ten units will be reserved for people earning 30% or less than the county’s median income. (According to the Portland Daily Journal of Commerce, Multnomah County’s 2-person household median income is $32,580.)

Armstrong Stafford LCC, the developer of Shaver Green, also hopes the building will achieve LEED Gold or Platinum certification. The structure will include solar panels, recycle 95 percent of its construction and demolition waste, and use stormwater for irrigation. The property is also being built to have a lifespan of at least 60 years, and therefore will offer significantly more sustainability than a typical affordable housing project.

The project received funding from the Portland Development Commission, the Interstate Corridor Urban Renewal Area, and federal HOME funds.

Photo Credit:

Read more about affordable housing:



Ectopic pregnancy occurs when a fertilized ovum implants on any tissue other than the endometrial lining of the uterus. Approximately l%-2% of pregnancies in the United States are ectopic (1,2); however, these pregnancies account for 3%- 4% of pregnancy-related deaths (3). The ectopic pregnancy mortality ratio in the United States decreased from 1.15 deaths per 100,000 live births in 1980-1984 to 0.50 in 2003-2007 (4). During 1999-2008, the ectopic pregnancy mortality ratio in Florida was similar to the national rate, 0.6 deaths per 100,000 live births, but increased abruptly to 2.5 during 2009-2010. Florida’s Pregnancy- Associated Mortality Review (PAMR) identified ectopic pregnancy deaths during 1999-2010 through its routine process of identifying all pregnancy- related deaths. A multidisciplinary investigation committee reviewed the ectopic pregnancy deaths for cause of death, risk factors, and prevention opportunities. This report summarizes the investigation results, which identified 11 ectopic pregnancy deaths from 2009-2010 and 13 deaths from the 10-year period 1999-2008. The increase in ectopic mortality appears to be associated with illicit drug use and delays in seeking health care. The findings underscore the importance of ongoing, statebased identification and review of pregnancy- related deaths. Such reviews have the potential to identify emerging causes of deaths and associated risk factors, such as ectopic pregnancy deaths among women who use illicit drugs. Efforts to prevent ectopic pregnancy deaths need to ensure early access to care, promote awareness about early pregnancy testing and ectopic pregnancy risk, and raise public awareness about substance abuse health risks, especially during pregnancy.

In 1996, the Florida Department of Health initiated PAMR to improve surveillance of pregnancy-related deaths in Florida. PAMR was formed to highlight gaps in health care, identify systematic service delivery problems, and make recommendations to facilitate improvements in the overall systems of care. The PAM R process begins by identifying pregnancy- associated deaths. A pregnancy-associated death is defined as occurring during or within 1 year after the end of pregnancy; the association is purely temporal. Pregnancy-associated deaths occurring within the previous year are identified through a quarterly review, using a computer algorithm examining linked data files from 1) death certificates of females aged 8-61 years, 2) statewide prenatal risk screenings for high-risk pregnancies, 3) certificates of live birth, and 4) fetal death certificates. The pregnancy-associated death certificates identified through this computer algorithm are reviewed by a PAMR subcommittee to determine if the death is pregnancy- related and to assign an underlying cause of death. A pregnancy- related death is defined as a pregnancy- associated death resulting from 1) complications of the pregnancy itself, 2) a chain of events initiated by the pregnancy that led to the death, or 3) aggravation of an unrelated condition by the physiologic or pharmacologic effects of the pregnancy that resulted in death. The PAMR subcommittee identified 470 pregnancy-related deaths that occurred during 1999-2010.

In late 2010, the PAMR subcommittee identified a potential increase in ectopic pregnancy deaths in 2009. A retrospective review of the identified pregnancy- related deaths from 1999-2009 confirmed this increase. Ectopic pregnancy deaths in 2010 were identified by a prospective review of the pregnancy-associated deaths for 2010. The PAMR subcommittee found that 24 ectopic pregnancy-related deaths had occurred during 1999-2010. go to web site countdown to pregnancy

PAMR staff members abstracted physician, hospital, medical examiner, health department, prenatal screening, and other records of all ectopic pregnancy deaths in Florida. Characteristics of the ectopic pregnancy deaths (e.g., sociodemographics, health history, and events surrounding death) were identified from available data sources. A multidisciplinary investigation committee systematically reviewed the de-identified abstracted records for causes of death, risk factors, and prevention opportunities. For deaths that occurred during 2009-2010, copies of original health records were obtained to ensure completeness. Statewide hospital discharge, ambulatory care, outpatient surgery, and emergency department databases also were searched to find evidence of other health-care encounters. Ectopic pregnancy mortality ratios were calculated as numbers of deaths per 100,000 live births using natality files for the denominator. Poisson distribution was used to calculate 95% confidence intervals. Significance was assessed using the mid-p exact test (p<0.05).

The PAMR subcommittee identified 368 pregnancyrelated deaths from 1999-2008 and 102 pregnancy-related deaths from 2009-2010. For the period 1999-2008, 13 ectopic pregnancy- related deaths were identified in Florida, comprising 3.5% of all pregnancy- related deaths. For the period 2009-2010, 1 1 ectopic pregnancy-related deaths were identified, comprising 10.8% of all pregnancy-related deaths. All 24 deaths were confirmed ectopic pregnancy diagnoses and were related to pregnancy in an oviduct. In comparison with the earlier period, the ectopic pregnancy mortality ratios for 2009-2010 were significantly higher among women who were non-Hispanic white (2.0 versus 0.3 deaths per 100,000 live births in 1999-2008), Hispanic (3.3 versus 0.0), unmarried (4.8 versus 0.7), without insurance or a health plan (17.6 versus 1.8), and had less than a high school education (6.4 versus 0.8) (Table).

During 2009-2010, the women who died were more likely to have collapsed, presumably from hemorrhage associated with acute tubal rupture, before seeking health care, compared with women who died during 1999-2008 (1.8 versus 0.3 deaths per 100,000 live births during 1999-2008). Of the eight women who collapsed during 2009-2010, six tested positive at autopsy for illicit drug use; exposure for one death was unknown. Four women tested positive for cocaine. No comparison could be made between the frequencies of illicit drug use among women who died from ectopic pregnancy during 1999-2008 and 2009-2010 because testing for illicit drug use was performed substantially less often in the earlier period. During 2009-2010, among the three women who sought care before collapse, two experienced a delay in medical diagnosis. Five of six women experienced similar delays in medical diagnosis during 1999-2008. go to web site countdown to pregnancy

Editorial Note

Ectopic pregnancy mortality rates in the United States steadily declined during the late 20th century, through 2007 (4). The decline in these deaths has been attributed to improvements in the sensitivity, accuracy, and use of pregnancy testing, ultrasound for diagnosis, and improvements in therapeutic modalities, including laparoscopic surgery and medical management of ectopic pregnancy. This success relies heavily on access to early care so that women who have signs and symptoms of ectopic pregnancy can be identified, diagnosed, and treated. The contribution of any change in the incidence of ectopic pregnancy to the decline in mortality is unknown. Obtaining a reliable incidence rate for ectopic pregnancy in the United States is difficult. The latest estimate of 19.7 ectopic pregnancies per 1,000 pregnancies in the United States for 1990-1992 was reported using inpatient National Hospital Discharge Survey and outpatient National Hospital Ambulatory Medical Care Survey data (5). However, hospital discharge data are no longer considered an accurate surveillance data source for all ectopic pregnancies because more of these pregnancies are managed on an outpatient basis and with nonsurgical interventions. Other surveillance approaches suggest that the frequency of ectopic pregnancy in the United States has not changed substantially in the United States since the early 1990s (6,7).

The 11 ectopic pregnancy deaths in Florida during 20092010 contrast with a total of 14 deaths in the entire United States attributable to ectopic pregnancy identified in national vital statistics for 2007, the most recent year for which national data are available (S). Compared with the earlier period, this series of ectopic pregnancy deaths in Florida during 2009-20 1 0 is associated with a higher proportion of women who collapsed, which is generally associated with acute tubal rupture and hemorrhage. Based on limited evidence from household and family members and from electronic hospital, outpatient surgery, and emergency department records, these women had not received any health care before collapse. These findings suggest that delays in obtaining care contributed to the deaths of these women. More often, these women were from disadvantaged groups of women who might have experienced difficulties accessing health care, such as women not covered by insurance or a health plan. The high prevalence of illicit drug users among deaths in Florida during 2009-201 0 might have been associated with delays in seeking care, receiving care, or both; this presents a challenge for prevention. The lack of drug testing in the earlier period limits the ability to ascertain whether the recent increase was predominantly related to illicit drug use.

This is the first report of an abrupt increase in ectopic pregnancy deaths identified in the United States in recent times. Pregnancy- related mortality surveillance systems previously have identified various clusters, including a cluster of maternal deaths associated with barbiturate anesthetics in New York City (9) and excessive maternal mortality among members of a religious group in Indiana (10).

The findings in this report are subject to at least four limitations. First, the total number of ectopic pregnancy deaths in Florida was small. Second, complete medical histories were not obtainable for every woman who died, limiting available information on risk factors and services. Third, rates of ectopic pregnancy deaths could not be calculated based on ectopic pregnancies because an accurate system for surveillance for cases of ectopic pregnancy at the population level is not available. Finally, women who nearly died from ectopic pregnancy were not studied.

This report reinforces the need for pregnancy-related mortality surveillance and its potential for guiding public health actions to prevent future deaths. Based on the findings from its review, Florida’s PAMR team recommended promoting awareness among women and health-care providers, especially emergency-care providers, about ensuring early access to care and the importance of early suspicion and testing for pregnancy. The high prevalence of illicit drug use among the women who died highlights the need to raise public awareness about health risks associated with drug exposure during pregnancy.


What is already known on this topic?

Only 1%-2% of pregnancies in the United States are ectopic, yet these pregnancies account for 3%-4% of pregnancy- related deaths. The ectopic pregnancy mortality ratio in the United States decreased from 1.15 deaths per 100,000 live births during 1 980-1 984 to 0.50 during 2003-2007.

What is added by this report?

Florida’s ectopic pregnancy mortality ratio abruptly increased from 0.6 deaths per 100,000 live births during 1999-2008 to 2.5 during 2009-2010. The increase in ectopic mortality appears to be associated with illicit drug use and delays in seeking health care.

What are the implications for public health practice?

State-based pregnancy- related mortality surveillance is needed to guide public health actions to prevent future deaths. Efforts to prevent ectopic pregnancy deaths need to ensure early access to care, promote awareness about early pregnancy testing and ectopic pregnancy risk, and raise public attention about substance abuse health risks, especially during pregnancy.



1. CDC. Pregnancy-related mortality surveillance – United States, 19911999. MMWR 2003;52(No. SS-2).

2. Saraiya M, Berg CJ, Shulman H, Green CA, Atrash HK. Estimates of the annual number of clinically recognized pregnancies in the United States, 1981-1991. Am J Epidemiol 1999;149:1025-9.

3- Berg CJ, Callaghan WM, Syverson C, Henderson Z. Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol 2010;116:1302-9.

4. Creanga AA, Shapiro-Mendoza CK, Bish CL, Zane S, Berg CJ, Callaghan WM. Trends in ectopic pregnancy mortality in the United States 1980-2007. Obstet Gynecol 201 1;1 17:837-43.

5. CDC. Ectopic pregnancy- United States, 1990-1992.

6. Hoover KW, Tao G, Kent CK. Trends in the diagnosis and of ectopic pregnancy in the United States. Obstet Gynecol

7. Van Den Eeden SK, Shan J, Bruce C, Glasser M. Ectopic pregnancy rate and treatment utilization in a large managed care Obstet Gynecol 2005; 105; 1052-7.

8. Xu J, Kockanek KD, Murphy SL, et al. Deaths: final data for 2007. Natl Vital Stat Rep 20 10;58: 1-73. Available at nvsr58/nvsr58_19.pdf. Accessed February 9, 2012.

9. CDC. Maternal deaths associated with barbiturate anesthetics – New York City. MMWR 1986;35:579-82, 587.

10. KaunitzAM, SpenceC, DanielsonTS, RochatRW, Grimes DA Perinatal and maternal mortality in a religious group avoiding obstetric care. Am J Obstet Gynecol 1984;150:826-31.

[Author Affiliation]

Reported by

Dani Noell, Isaac Delke, MD, Washington C Hill, MD, Robert W Yelverton, MD, Donna L. Carden, MD, Margaret H. Neal MD, Florida Pregnancy Associated Mortality Review Team; Lindsay S. Womack, MPH, William M. Sappenfield, MD, Deborah L. Burch, Leticia E. Hernandez, PhD, Florida Dept of Health. William M. Calhghan, MD, Div of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, CDC. Corresponding contributor: Lindsay S. Womack, lindsay_womack@doh. state., 850-245-4444, ext. 2991.

« »

About the Author

Back to Top ↑